Pregnant diabetic rats fed the antioxidant butylated hydroxytoluene show decreased occurrence of malformations in offspring

Diabetes

Volumn 45, Issue 11, 1996, Pages 1497-1502

  Eriksson, Ulf J ^a   Simán, C Martin ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYLCRESOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONGENITAL MALFORMATION; CONTROLLED STUDY; EMBRYO CULTURE; EMBRYO DEVELOPMENT; FETUS OUTCOME; METABOLIC REGULATION; MORPHOGENESIS; NONHUMAN; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PROGENY; RAT; TERATOGENICITY;

EID: 0029957231     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.45.11.1497     Document Type: Article

References (49)

1. Kucera J: Rate and type of congenital anomalies among offspring of diabetic women. J Reprod Med 7:61-70,1971
2. Mills JL: Malformations in infants of diabetic mothers. Teratology 25:385-394,1982
3. Mølsted-Pedersen L, Kühl C: Obstetrical management in diabetic pregnancy: the Copenhagen experience. Diabetologia 29:13-16,1986
4. Hanson U, Persson B, Thunell S: Relationship between haemoglobin Alc in early type 1 (insulin-dependent) diabetic pregnancy and the occurrence of spontaneous abortion and fetal malformation in Sweden. Diabetologia 33:100-104,1990
5. Kitzmiller JL, Gavin LA, Gin GD, Jovanovic-Peterson L, Main EK, Zigrang WD: Preconception care of diabetes: glycemic control prevents congenital anomalies. JAMA 265:731-736, 1091
6. Baker L, Piddington R: Diabetic embryopathy: a selective review of recent trends. J Diabetic Complications 7:204-212,1993
7. Eriksson UJ, Borg LAH, Forsberg H, Simán CM, Suzuki N, Yang X: Can fetal loss be prevented? The biochemical basis of diabetic embryopathy. Diabetes Rev 4:49-69,1996
8. Eriksson UJ, Borg LAH: Protection by free oxygen radical scavenging enzymes against glucose-induced embryonic malformations in vitro. Diabetologia 34:326-331,1991
9. Eriksson UJ, Borg LAH: Diabetes and embryonic malformations: role of substrate-induced free-oxygen radical production for dysmorphogenesis in cultured rat embryos. Diabetes 42:411-419,1993
10. Yang X, Borg LAH, Eriksson UJ: Altered mitochondrial morphology of rat embryos in diabetic pregnancy. Anat Rec 241:255-267,1995
11. Trocino RA, Akazawa S, Ishibashi M, Matsumoto K, Matsuo H, Yamamoto H, Goto S, Urata Y, Kondo T, Nagataki S: Significance of glutathione depletion and oxidative stress in early embryogenesis in glucose-induced rat embryo culture. Diabetes 44:992-998,1995
12. Linklater HA, Dzialoszynski T, McLeod HL, Sanford SE Jr: Modelling cortical cataract VIII: effects of butylated hydroxytoluene (BHT) in reducing protein leakage from lenses in diabetic rats. Exp Eye Res 43:305-313,1986
13. Ansari NH, Srivastava SK: Allopurinol promotes and butylated hydroxy toluene prevents sugar-induced cataractogenesis. Biochem Biophys Res Commun 168:939-943,1990
14. Björkhem I, Henriksson-Freyschuss A, Breuer O, Diczfalusy U, Berglund L, Henriksson P: The antioxidant butylated hydroxytoluene protects against atherosclerosis. Arterioscler Thromb 11:15-22,1991
15. Tatsua M, Mikuni T, Taniguchi H: Protective effect of butylated hydroxytoluene against induction of gastric cancer by N-methyl-N′-nitro-N-nitrosoguanidine in Wistar rats. Int J Cancer 32:253-254,1983
16. Williams GM, Tanaka T, Maeura Y: Dose-related inhibition of aflatoxin B1 induced hepatocarcinogenesis by the phenolic antioxidants, butylated hydroxyanisole and butylated hydroxytoluene. Carcinogenesis 7:1043-1050,1986
17. McCormick DL, May CM, Thomas CF, Detrisac CJ: Anti carcinogenic and hepatotoxic interactions between retinyl acetate and butylated hydroxytoluene in rats. Cancer Res 46:5264-5269,1986
18. Eriksson UJ: Importance of genetic predisposition and maternal environment for the occurrence of congenital malformations in offspring of diabetic rats. Teratology 37:365-374,1988
19. Eriksson UJ, Dahlström E, Larsson KS, Hellerström C: Increased incidence of congenital malformations in the offspring of diabetic rats and their prevention by maternal insulin therapy. Diabetes 31:1-6,1982
20. Terao J, Magarian RA, Brueggemann G, King MM: Methods of extraction and high-performance liquid Chromatographic analysis of butylated hydroxytoluene from the tissues and serum of rats. Anal Biochem 151:445-454,1985
21. Ostle B: Statistics in Research. 2nd ed. Ames, IA, Iowa State University Press,1963
22. Winer BJ: Statistical Principles in Experimental Design. New York, McGraw-Hill,1971
23. Horii K, Watanabe G, Ingalls TH: Experimental diabetes in pregnant mice: prevention of congenital malformations in offspring by insulin. Diabetes 15:194-204,1966
24. Baker L, Egler JM, Klein SM, Goldman AS: Meticulous control of diabetes during organogenesis prevents congenital lumbosacral defects in rats. Diabetes 30:955-959,1981
25. Goldman AS, Baker L, Piddington R, Marx B, Herold R, Egler J: Hyperglycemia-induced teratogenesis is mediated by a functional deficiency of arachidonic acid. Proc Natl Acad Sci USA 82:8227-8231,1985
26. Viana M, Herrera E, Bonet B: Teratogenic effects of diabetes mellitus in the rat. Prevention with vitamin E. Diabetologia 39:1047-1054,1996
27. Simán CM, Borg LAH, Eriksson UJ: Vitamin E treatment blocks dysmorphogenesis in embryos of diabetic rats. Diabetologia 38 (Suppl. 1):A22,1995
28. Suzuki N, Svensson K, Eriksson UJ: Effects of increased glucose concentration and antioxidants on rat cranial neural crest cell development in vitro. Diabetologia 39:401-411,1996
29. Eriksson UJ, Borg LAH, Hagay Z, Groner Y: Increased Superoxide dismutase (SOD) activity in embryos of transgenic mice protects from the teratogenic effects of a diabetic environment. Diabetes 42 (Suppl. 1):85A,1993
30. Hagay ZJ, Weiss Y, Zusman I, Peled-Kamar M, Eriksson UJ, Groner Y: Prevention of hyperglycemia-associated embryopathy by embryonic overexpression of the free radical scavenger copper zinc Superoxide dismutase gene. Am J Obstet Gynecol 173:1036-1041,1995
31. Mills J, Baker L, Goldman AS: Malformations in infants of diabetic mothers occur before the seventh gestational week. Diabetes 28:292-293,1979
32. Eriksson UJ, Bone AJ, Turnbull DM, Baird JD: Timed interruption of insulin therapy in diabetic BB/E rat pregnancy: effects on maternal metabolism and fetal outcome. Acta Endocrinol (Copenhagen) 120:800-810,1989
33. Eriksson RSM, Thunberg L, Eriksson UJ: Effects of interrupted insulin treatment on fetal outcome of pregnant diabetic rats. Diabetes 38:764-772,1989
34. Thorogood P, Ferretti P: Heads and tales: recent advances in craniofacial development. Br Dent J 173:301-306,1992
35. Davis WL, Crawford LA, Cooper OJ, Farmer GR, Thomas DL, Freeman BL: Ethanol induces the generation of free radicals by neural crest cells in vitro. J Craniofacial Genet Dev Biol 10:277-293,1990
36. Cagliero E, Forsberg H, Sala R, Lorenzi M, Eriksson UJ: Maternal diabetes induces increased expression of extracellular matrix components in rat embryos. Diabetes 42:975-980,1993
37. Frawley JP, Kohn FE, Kay JH, Calandra JC: Progress report on multigeneration reproduction studies in rats fed butylated hydroxytoluene (BHT). Food Cosmet Toxicol 3:377-386,1965
38. Stokes JD, Scudder CJ: The effect of butylated hydroxyanisole and butylated hydroxytoluene on behavioral development of mice. Dev Psychobiol 7:34:3-350,1974
39. Vorhees CV, Butcher RE, Brunner RL, Sobotka TJ: Developmental neurobehavioural toxicity of butylated hydroxytoluene in rats. Food Cosmet Toxicol 19:153-162,1981
40. Tanaka T, Oishi S, Takahashi O: Three generation toxicity study of butylated hydroxytoluene administered to mice. Toxicol Lett 66:295-304,1993
41. Witschi H, Williamson D, Lock S: Enhancement of urethane tumorigenesis in mouse lung by butylated hydroxytoluene. J Natl Cancer Inst 58:301-305,1977
42. Malkinson AM, Beer DS: Pharmacological and genetic studies on the modulatory effects of butylated hydroxytoluene on mouse lung adenoma formation. J Natl Cancer Inst 73:925-933,1984
43. Bolton JL, Valerio LG Jr, Thompson JA: The enzymatic formation and chemical reactivity of quinone methides correlate with alkylphenol-induced toxicity in rat hepatocytes. Chem Res Toxicol 5:816- 822,1992
44. Brown WD, Johnson AR, O'Halloran MW: The effect of the level of dietary fat on the toxicity of phenolic antioxidants. Aust J Exp Biol 37:533-548,1959
45. Simán CM, Eriksson UJ: Effect of butylated hydroxytoluene on α-tocopherol in liver and fat tissue of rats. Toxicol Lett 87:103-108,1996
46. Bolton JL, Thompson JA: Oxidation of butylated hydroxytoluene to toxic metabolites: factors influencing hydroxylation and quinone methide formation by hepatic and pulmonary mirrosomes. Drug Metab Disposition 19:467-472,1991
47. Powell CJ, Connolly AK: The site specificity and sensitivity of the rat liver to butylated hydroxytoluene-induced damage. Toxicol Appl Pharmacol 108:67-77,1991
48. Flyvholm MA, Menné T: Sensitizing risk of butylated hydroxytoh ene based on exposure and effect data. Contact Dermatitis 23:341-345,1990
49. Styrud J, Thunberg L, Nybacka O, Eriksson UJ: Correlations between maternal metabolism and deranged development in the offspring of normal and diabetic rats. Pediatr Res 37:343-353,1995